Key Highlights
- IRBM's unified research facility enables rapid and efficient drug discovery, making it a valuable partner for companies seeking to accelerate their development timelines.
- The company's deep collaborations with leading global institutions provide access to cutting-edge expertise and technologies, enhancing its ability to deliver innovative solutions.
- IRBM's internal pipeline of oncology and other therapeutic assets demonstrates its commitment to advancing treatments and improving patient outcomes.
- The company's comprehensive in-house capabilities streamline the drug development process, helping partners achieve key milestones and progress towards clinical readiness.
- IRBM's position as a major player in the pharmaceutical and biotech fields underscores its reputation for driving innovation and delivering impactful results.
About IRBM
IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate. With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields. Find more detailed information available on our website below.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
Office Locations
- Boston, USA
Why Contact IRBM?
B2B professionals should contact IRBM for its unparalleled expertise in drug discovery and development, as well as its ability to accelerate the development process and deliver innovative solutions.
Who Should Contact IRBM for Business?
Sales teams selling pharmaceutical and biotech products, recruiters seeking experienced scientists and researchers, and partners offering complementary technologies and services.
Categories
- drug discovery
- pharmaceutical research
- biotechnology
- clinical readiness
- oncology
- therapeutic assets
- research facility
- global institutions
- innovation
- collaborations
More Pharmaceutical Research Companies
Frequently Asked Questions
- Who is the CEO of IRBM?
- The CEO of IRBM is Matteo Liguori.
- What does IRBM do?
- IRBM is a scientific contract research organization (CRO) and drug discovery company that specializes in cancer, neurological disorders, infection, and rare diseases, offering services from target identification to clinical candidate selection.
- How many employees does IRBM have?
- IRBM has approximately 286 employees.
- Where is IRBM headquartered?
- IRBM is headquartered in Italy, with a recently opened international office in Boston.
- What industry is IRBM in?
- IRBM operates in Pharmaceutical Research, Biotechnology Development, Drug Discovery Services.
- When was IRBM founded?
- IRBM was founded in 2009.
- Is IRBM still active?
- Yes, IRBM was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to IRBM?
- Research IRBM's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to IRBM?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with IRBM